340 related articles for article (PubMed ID: 32113693)
21. Primary Cytomegalovirus Infection Significantly Impacts Circulating T Cells in Kidney Transplant Recipients.
Meijers RW; Litjens NH; Hesselink DA; Langerak AW; Baan CC; Betjes MG
Am J Transplant; 2015 Dec; 15(12):3143-56. PubMed ID: 26211927
[TBL] [Abstract][Full Text] [Related]
22. Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose Valganciclovir.
Nanmoku K; Shinzato T; Kubo T; Shimizu T; Kimura T; Yagisawa T
Transplant Proc; 2018; 50(1):124-129. PubMed ID: 29407294
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
Opelz G; Daniel V; Naujokat C; Döhler B
Transplantation; 2009 Oct; 88(8):962-7. PubMed ID: 19855238
[TBL] [Abstract][Full Text] [Related]
24. Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system?
Wong G; Chakera A; Chapman JR; Chadban SC; Pilmore H; Craig JC; Lim WH
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27860123
[TBL] [Abstract][Full Text] [Related]
25. Association between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.
Oh IH; Lee CH; Kim GH; Kang CM; Park JS
Artif Organs; 2015 Mar; 39(3):254-9. PubMed ID: 25205383
[TBL] [Abstract][Full Text] [Related]
26. Impact of Cytomegalovirus on Long-term Mortality and Cancer Risk After Organ Transplantation.
Desai R; Collett D; Watson CJ; Johnson PJ; Moss P; Neuberger J
Transplantation; 2015 Sep; 99(9):1989-94. PubMed ID: 25706273
[TBL] [Abstract][Full Text] [Related]
27. Patient years lost due to cytomegalovirus serostatus mismatching in the scientific registry of transplant recipients.
Abidi MZ; Schold JD; Kaplan B; Weinberg A; Erlandson KM; Malamon JS
Front Immunol; 2023; 14():1292648. PubMed ID: 38264645
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.
Selvey LA; Lim WH; Boan P; Swaminathan R; Slimings C; Harrison AE; Chakera A
BMC Infect Dis; 2017 Jul; 17(1):501. PubMed ID: 28716027
[TBL] [Abstract][Full Text] [Related]
29. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.
Harvala H; Stewart C; Muller K; Burns S; Marson L; MacGilchrist A; Johannessen I
J Med Virol; 2013 May; 85(5):893-8. PubMed ID: 23508914
[TBL] [Abstract][Full Text] [Related]
30. Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States.
Kurihara C; Fernandez R; Safaeinili N; Akbarpour M; Wu Q; Budinger GRS; Bharat A
Ann Thorac Surg; 2019 Apr; 107(4):1046-1052. PubMed ID: 30476471
[TBL] [Abstract][Full Text] [Related]
31. Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: Long-term Results After 7 Years of a Randomized Clinical Trial.
Witzke O; Nitschke M; Bartels M; Wolters H; Wolf G; Reinke P; Hauser IA; Alshuth U; Kliem V
Transplantation; 2018 May; 102(5):876-882. PubMed ID: 29166336
[TBL] [Abstract][Full Text] [Related]
32. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation.
Arthurs SK; Eid AJ; Pedersen RA; Kremers WK; Cosio FG; Patel R; Razonable RR
Clin Infect Dis; 2008 Mar; 46(6):840-6. PubMed ID: 18260785
[TBL] [Abstract][Full Text] [Related]
33. Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients.
Rittà M; Costa C; Sidoti F; Ballocco C; Ranghino A; Messina M; Biancone L; Cavallo R
New Microbiol; 2015 Jul; 38(3):329-35. PubMed ID: 26147141
[TBL] [Abstract][Full Text] [Related]
34. Reduced rate of cardiovascular death after cytomegalovirus prophylaxis in renal transplant recipients.
Opelz G; Döhler B
Transplantation; 2015 Jun; 99(6):1197-202. PubMed ID: 25606797
[TBL] [Abstract][Full Text] [Related]
35. Burden of cytomegalovirus reactivation post kidney transplant with antithymocyte globulin use in Thailand: A retrospective cohort study.
Chitasombat MN; Watcharananan SP
F1000Res; 2018; 7():1568. PubMed ID: 30473779
[No Abstract] [Full Text] [Related]
36. The Association of 25-Hydroxyvitamin D Levels with Late Cytomegalovirus Infection in Kidney Transplant Recipients: the Wisconsin Allograft Recipient Database.
Astor BC; Djamali A; Mandelbrot DA; Parajuli S; Melamed ML
Transplantation; 2019 Aug; 103(8):1683-1688. PubMed ID: 30801528
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice.
Fernández-Ruiz M; Arias M; Campistol JM; Navarro D; Gómez-Huertas E; Gómez-Márquez G; Díaz JM; Hernández D; Bernal-Blanco G; Cofan F; Jimeno L; Franco-Esteve A; González E; Moreso FJ; Gómez-Alamillo C; Mendiluce A; Luna-Huerta E; Aguado JM;
Transpl Int; 2015 Sep; 28(9):1042-54. PubMed ID: 25864986
[TBL] [Abstract][Full Text] [Related]
39. Pretransplant recipient cytomegalovirus seropositivity and hemodialysis are associated with decreased renal allograft and patient survival.
Fitzgerald JT; Gallay B; Taranto SE; McVicar JP; Troppmann C; Chen X; McIntosh MJ; Perez RV
Transplantation; 2004 May; 77(9):1405-11. PubMed ID: 15167599
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus.
Chen Y; Xu LP; Liu KY; Chen H; Chen YH; Zhang XH; Wang Y; Wang FR; Han W; Wang JZ; Yan CH; Huang XJ
J Clin Virol; 2016 Feb; 75():10-5. PubMed ID: 26735213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
